Literature DB >> 13786515

The relationship of cellular permeability to the degree of inhibition by amethopterin and pyrimethamine in several species of bacteria.

R C WOOD, R FERONE, G H HITCHINGS.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/pharmacology; ESCHERICHIA COLI/pharmacology; FOLIC ACID ANTAGONISTS/pharmacology; LACTOBACILLUS/pharmacology; STREPTOCOCCUS FAECALIS/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 13786515     DOI： 10.1016/0006-2952(61)90155-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

Review 1.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

2.  [Effect and istribution of methotrexate in the human organism during leukemia treatment].

Authors:  W Wilmanns; H Martin
Journal:  Klin Wochenschr       Date:  1968-03-15

3.  Separation of folic acid reductase from Streptococcus faecium (ATCC 8043).

Authors:  E L Speck; L F Affronti
Journal:  J Bacteriol       Date:  1969-03       Impact factor: 3.490

4.  Dihydrofolate reductases in some folate-requiring bacteria with low trimethoprim susceptibility.

Authors:  R L Then; H Riggenbach
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

5.  Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation.

Authors:  Renuka R Nayak; Margaret Alexander; Ishani Deshpande; Kye Stapleton-Gray; Bipin Rimal; Andrew D Patterson; Carles Ubeda; Jose U Scher; Peter J Turnbaugh
Journal:  Cell Host Microbe       Date:  2021-01-12       Impact factor: 21.023

6.  Studies concerned with overcoming resistance to methotrexate: a comparison of the effects of methotrexate and 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (BW50197) on the colony forming ability of L5178Y cells.

Authors:  B T Hill; J H Goldie; L A Price
Journal:  Br J Cancer       Date:  1973-09       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.